The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 25, 2021

Filed:

Apr. 08, 2019
Applicant:

Ucb Biopharma Srl, Brussels, BE;

Inventors:

John Robert Adair, High Wycombe, GB;

Diljeet Singh Athwal, London, GB;

John Spencer Emtage, Marlow, GB;

Assignee:

UCB Biopharma SRL, Brussels, BE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2005.12); C07K 14/46 (2005.12); C07K 16/46 (2005.12);
U.S. Cl.
CPC ...
C07K 14/461 (2012.12); C07K 16/461 (2012.12); C07K 2317/64 (2012.12);
Abstract

CDR-grafted antibody heavy and light chains comprise acceptor framework and donor antigen binding regions, the heavy chains comprising donor residues at at least one of positions (6, 23) and/or (24, 48) and/or (49, 71) and/or (73, 75) and/or (76) and/or (78) and (88) and/or (91). The CDR-grafted light chains comprise donor residues at at least one of positions (1) and/or (3) and (46) and/or (47) or at at least one of positions (46, 48, 58) and (71). The CDR-grafted antibodies are preferably humanized antibodies, having non human, e.g. rodent, donor and human acceptor frameworks, and may be used for in vivo therapy and diagnosis. A generally applicable protocol is disclosed for obtaining CDR-grafted antibodies.


Find Patent Forward Citations

Loading…